Evidence map›Paper›PMID 27380525›Full record

ArticlePloS one2016

HRP2 and pLDH-Based Rapid Diagnostic Tests, Expert Microscopy, and PCR for Detection of Malaria Infection during Pregnancy and at Delivery in Areas of Varied Transmission: A Prospective Cohort Study in Burkina Faso and Uganda.

Daniel J Kyabayinze, Issaka Zongo, Jane Cunningham, Michelle Gatton, Patrick Angutoko, John Ategeka, Yves-Daniel Compaoré, Atis Muehlenbachs, Jerry Mulondo, Miriam Nakalembe and 6 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 3 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 3 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. UndetectedMalariaWorld journal · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. An overview of malaria in pregnancy.Seminars in perinatology · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 5 countries.

Daniel J KyabayinzeFoundation for Innovative New Diagnostics, Kampala, Uganda.
Issaka ZongoInstitut de Recherche en Sciences de la Santé (IRSS), Direction Régionale de l'Ouest, Bobo-Dioulasso, Burkina Faso.
Jane CunninghamUNICEF/UNDP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases (TDR), Geneva, Switzerland.
Michelle GattonSchool of Public Health and Social Work, Queensland University of Technology, Queensland, Australia.ORCID http://orcid.org/0000-0003-1188-609X
Patrick AngutokoFoundation for Innovative New Diagnostics, Kampala, Uganda.
John AtegekaFoundation for Innovative New Diagnostics, Kampala, Uganda.
Yves-Daniel CompaoréInstitut de Recherche en Sciences de la Santé (IRSS), Direction Régionale de l'Ouest, Bobo-Dioulasso, Burkina Faso.
Atis MuehlenbachsDepartment of Pathology, University of Washington, Seattle, Washington, United States of America.
Jerry MulondoFoundation for Innovative New Diagnostics, Kampala, Uganda.ORCID http://orcid.org/0000-0001-8106-5057
Miriam NakalembeDepartment of Obstetrics & Gynecology, Makerere University College of Health Sciences, Kampala, Uganda.ORCID http://orcid.org/0000-0001-7569-8173
Fabrice A SoméInstitut de Recherche en Sciences de la Santé (IRSS), Direction Régionale de l'Ouest, Bobo-Dioulasso, Burkina Faso.
Aminata OuattaraInstitut de Recherche en Sciences de la Santé (IRSS), Direction Régionale de l'Ouest, Bobo-Dioulasso, Burkina Faso.
Noél RouambaInstitut de Recherche en Sciences de la Santé (IRSS), Direction Régionale de l'Ouest, Bobo-Dioulasso, Burkina Faso.
Jean-Bosco OuédraogoInstitut de Recherche en Sciences de la Santé (IRSS), Direction Régionale de l'Ouest, Bobo-Dioulasso, Burkina Faso.
Heidi HopkinsFoundation for Innovative New Diagnostics, Kampala, Uganda.
David BellFoundation for Innovative New Diagnostics, Geneva, Switzerland.ORCID http://orcid.org/0000-0002-7010-6340
Institut de Recherche en Sciences de la Santé · BFFIND · CHMakerere University · UGQueensland University of Technology · AUUniversity of Washington · USWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundIntermittent screening and treatment (IST) of malaria during pregnancy has been proposed as an alternative to intermittent preventive treatment in pregnancy (IPTp), where IPTp is failing due to drug resistance. However, the antenatal parasitaemias are frequently very low, and the most appropriate screening test for IST has not been defined. METHODOLOGY/PRINCIPAL

findingsWe conducted a multi-center prospective study of 990 HIV-uninfected women attending ANC in two different malaria transmission settings at Tororo District Hospital, eastern Uganda and Colsama Health Center in western Burkina Faso. Women were enrolled in the study in the second or third trimester of pregnancy and followed to delivery, generating 2,597 blood samples for analysis. Screening tests included rapid diagnostic tests (RDTs) targeting histidine-rich protein 2 (HRP2) and parasite lactate dehydrogenase (pLDH) and microscopy, compared to nPCR as a reference standard. At enrolment, the proportion of pregnant women who were positive for P. falciparum by HRP2/pan pLDH RDT, Pf pLDH/pan pLDH RDT, microscopy and PCR was 38%, 29%, 36% and 44% in Uganda and 21%, 16%, 15% and 35% in Burkina Faso, respectively. All test positivity rates declined during follow-up. In comparison to PCR, the sensitivity of the HRP2/pan pLDH RDT, Pf pLDH/pan pLDH RDT and microscopy was 75.7%, 60.1% and 69.7% in Uganda, 55.8%, 42.6% and 55.8% in Burkina Faso respectively for all antenatal visits. Specificity was greater than 96% for all three tests. Comparison of accuracy using generalized estimating equation revealed that the HRP2- detecting RDT was the most accurate test in both settings. CONCLUSIONS/SIGNIFICANCE: The study suggests that HRP2-based RDTs are the most appropriate point-of-care test currently available for use during pregnancy especially for symptomatic women, but will still miss some PCR-positive women. The clinical significance of these very low density infections needs to be better defined.

Indexed as

AdultAntigens, ProtozoanBurkina FasoDiagnostic Tests, RoutineFemaleFollow-Up StudiesHost-Parasite InteractionsHumansInfant, NewbornL-Lactate DehydrogenaseMalaria, FalciparumMicroscopyPlasmodium falciparumPoint-of-Care SystemsPolymerase Chain ReactionPregnancyAntigens, ProtozoanHRP-2 antigen, Plasmodium falciparumL-Lactate DehydrogenaseProtozoan Proteins

Identifiers

PMID27380525
PMCPMC4933335
OpenAlexW2460907954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.